Clinical Trial Update: First in Man Study With SLV341 [Phase 1]

View source ↗

Summary

First-in-man Phase 1 study of SLV341 for diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SLV341

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Diabetes | Phase 1 | Status: TERMINATED